We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+23.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$185M
AUM Growth
+$16.5M
(+9.8%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-54.06%
Top 10 Holdings %
Top 10 Hldgs %
35.61%
Holding
185
New
26
Increased
36
Reduced
26
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELVA
Electrovaya
ELVA
|
+$2.28M |
| 2 |
PROF
Profound Medical
PROF
|
+$1.53M |
| 3 |
SCPH
scPharmaceuticals
SCPH
|
+$1.33M |
| 4 |
LivePerson
LPSN
|
+$1.23M |
| 5 |
Red Cat Holdings
RCAT
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aviat Networks
AVNW
|
+$2.34M |
| 2 |
Everspin Technologies
MRAM
|
+$2.08M |
| 3 |
Markel Group
MKL
|
+$1.23M |
| 4 |
Broadwind
BWEN
|
+$793K |
| 5 |
argenx
ARGX
|
+$737K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.35% |
| 2 | Technology | 13.11% |
| 3 | Financials | 6.55% |
| 4 | Industrials | 6.29% |
| 5 | Real Estate | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Myomo
MYO
$37.5M
| $7M | 3.78% |
1,397,861
| – | – |
|
2
Aspen Aerogels
ASPN
$387M
| $6.96M | 3.76% |
440,988
+12,621
| +3% | +$130K |
|
|
SCPH
3
DELISTED
scPharmaceuticals
SCPH
| $4.84M | 2.61% |
771,344
+231,679
| +43% | +$1.33M |
|
4
indie Semiconductor
INDI
$733M
| $4.63M | 2.5% |
570,512
+35,759
| +7% | +$233K |
|
|
TGAN
5
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $4.21M | 2.28% |
1,153,778
+1,500
| +0.1% | +$4.11K |
|
6
Ouster
OUST
$2.29B
| $3.6M | 1.95% |
469,312
+154,402
| +49% | +$809K |
|
7
Capital One
COF
$124B
| $2.72M | 1.47% |
20,723
+3,062
| +17% | +$330K |
|
8
Hilton Grand Vacations
HGV
$3.84B
| $2.65M | 1.43% |
65,976
+26,435
| +67% | +$992K |
|
|
ELVA
9
Electrovaya
ELVA
$412M
| $2.51M | 1.36% |
+820,538
| New | +$2.28M |
|
|
ALIM
10
DELISTED
Alimera Sciences
ALIM
| $2.4M | 1.3% |
556,642
-37,067
| -6% | -$125K |
|
11
OneMain Financial
OMF
$6.9B
| $2.38M | 1.29% |
48,433
| – | – |
|
12
TELA Bio
TELA
$30.9M
| $2.29M | 1.24% |
345,331
+31,111
| +10% | +$180K |
|
13
Progressive
PGR
$124B
| $2.25M | 1.22% |
14,120
-1,127
| -7% | -$176K |
|
14
Biodesix
BDSX
$228M
| $2.1M | 1.14% |
57,090
-3,028
| -5% | -$95.1K |
|
15
Cellectar Biosciences
CLRB
$19.3M
| $1.92M | 1.04% |
23,130
+13,826
| +149% | +$1.03M |
|
16
Apollo Global Management
APO
$70.7B
| $1.86M | 1.01% |
20,002
-7,501
| -27% | -$662K |
|
|
BWAY
17
Brainsway
BWAY
$641M
| $1.68M | 0.91% |
517,068
-156,218
| -23% | -$378K |
|
18
Fennec Pharmaceuticals
FENC
$347M
| $1.59M | 0.86% |
141,500
+48,864
| +53% | +$405K |
|
|
SPRB
19
Spruce Biosciences
SPRB
$119M
| $1.54M | 0.83% |
7,026
+2,998
| +74% | +$346K |
|
|
20
LivePerson
LPSN
$18.9M
| $1.52M | 0.82% |
+26,714
| New | +$1.23M |
|
21
Bank of America
BAC
$435B
| $1.5M | 0.81% |
44,667
+2,263
| +5% | +$65.9K |
|
22
Franklin Covey
FC
$233M
| $1.5M | 0.81% |
34,405
-13,773
| -29% | -$546K |
|
|
THTX
23
DELISTED
Theratechnologies
THTX
| $1.47M | 0.79% |
906,557
+710,551
| +363% | +$1.07M |
|
|
ITI
24
DELISTED
Iteris, Inc.
ITI
| $1.45M | 0.78% |
278,790
-3,476
| -1% | -$15.3K |
|
25
Raymond James Financial
RJF
$32.5B
| $1.41M | 0.76% |
12,660
-375
| -3% | -$38.6K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Worth Venture Partners held 185 positions worth $185M, up 9.8% from $169M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Worth Venture Partners withdrew a net $100M in Q4 2023, closing 56 positions and reducing 26 holdings. Its most notable exit was Aviat Networks, an estimated $2.34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Worth Venture Partners opened a new position in Electrovaya worth $2.51M.
- Worth Venture Partners's largest Q4 2023 buy was Electrovaya: 820,538 shares worth $2.51M.
- Worth Venture Partners added most to scPharmaceuticals in Q4 2023, an estimated $1.33M increase.
- Worth Venture Partners's biggest Q4 2023 reduction was Apollo Global Management, cutting an estimated $662K.
- Worth Venture Partners fully exited Aviat Networks in Q4 2023, selling an estimated $2.34M.
- Worth Venture Partners's ten largest holdings make up 36% of its $185M portfolio in Q4 2023.
- Worth Venture Partners opened 26 new positions and closed 56 in Q4 2023.
- Worth Venture Partners's portfolio value rose 9.8% quarter-over-quarter to $185M.
Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.